Results 211 to 220 of about 180,751 (262)
Hydrogel Loaded with Aminoethyl Anisamide-Modified Exosomes Attenuates Hepatic Fibrosis by Targeting Activated Hepatic Stellate Cells. [PDF]
ACS NanoSun Z +13 more
europepmc +1 more source
Revisiting Hepatic Fibrosis Risk in Congenital Heart Disease: Insights from Non-Invasive Markers and Echocardiography. [PDF]
Children (Basel)Yamazaki F +23 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Hepatology, 1988
We report the clinical features of 7 men (mean age 22 years, range 7-53 years) with congenital hepatic fibrosis (CHF). Five patients presented with variceal bleeding and/or hepatosplenomegaly due to portal hypertension. Cholangitis was the presenting symptom in the other 2 cases. Diagnosis was established by histological examination of a surgical wedge
M, De Vos, F, Barbier, C, Cuvelier
openaire +2 more sources
We report the clinical features of 7 men (mean age 22 years, range 7-53 years) with congenital hepatic fibrosis (CHF). Five patients presented with variceal bleeding and/or hepatosplenomegaly due to portal hypertension. Cholangitis was the presenting symptom in the other 2 cases. Diagnosis was established by histological examination of a surgical wedge
M, De Vos, F, Barbier, C, Cuvelier
openaire +2 more sources
Australasian Annals of Medicine, 1962
SUMMARYA family with a high incidence of hepatomegaly, normal liver function and stillbirths is described. In one member biopsy material confirmed the diagnosis of congenital hepatic fibrosis. This patient's sister probably died of the same disorder. Unusual hepatic sinusoidal prominence was present in the patient described and in one of her daughters,
J B, HICKIE, J M, GARVAN
openaire +2 more sources
SUMMARYA family with a high incidence of hepatomegaly, normal liver function and stillbirths is described. In one member biopsy material confirmed the diagnosis of congenital hepatic fibrosis. This patient's sister probably died of the same disorder. Unusual hepatic sinusoidal prominence was present in the patient described and in one of her daughters,
J B, HICKIE, J M, GARVAN
openaire +2 more sources
Toxicology, 2008
The study of hepatic fibrosis, or scarring in response to chronic liver injury, has witnessed tremendous progress in the past two decades. Clarification of the cellular sources of scar, and emergence of hepatic stellate cells not only as a fibrogenic cell type, but also as a critical immunomodulatory and homeostatic regulator are among the most salient
openaire +2 more sources
The study of hepatic fibrosis, or scarring in response to chronic liver injury, has witnessed tremendous progress in the past two decades. Clarification of the cellular sources of scar, and emergence of hepatic stellate cells not only as a fibrogenic cell type, but also as a critical immunomodulatory and homeostatic regulator are among the most salient
openaire +2 more sources
Archives of Surgery, 1965
CONGENITAL hepatic fibrosis is a rare cause of intrahepatic portal hypertension in children or young adults. Hepatic function is well preserved, as in extrahepatic obstruction, making these patients acceptable candidates for surgical decompression of their portal hypertension.
openaire +2 more sources
CONGENITAL hepatic fibrosis is a rare cause of intrahepatic portal hypertension in children or young adults. Hepatic function is well preserved, as in extrahepatic obstruction, making these patients acceptable candidates for surgical decompression of their portal hypertension.
openaire +2 more sources
Targeting Hepatic Fibrosis in Autoimmune Hepatitis
Digestive Diseases and Sciences, 2016Hepatic fibrosis develops or progresses in 25Â % of patients with autoimmune hepatitis despite corticosteroid therapy. Current management regimens lack reliable noninvasive methods to assess changes in hepatic fibrosis and interventions that disrupt fibrotic pathways.
Aldo J, Montano-Loza +2 more
openaire +2 more sources
Seminars in Liver Disease, 1990
Although there is no established therapy for the fibrogenesis of hepatic cirrhosis, many potential therapies are now emerging. The requirements for the "perfect therapy" for hepatic fibrosis can be listed: (1) the pharmacologic agent should be active only in the liver; (2) its effect should be specific for collagen (or another critical extracellular ...
D A, Brenner, J M, Alcorn
openaire +2 more sources
Although there is no established therapy for the fibrogenesis of hepatic cirrhosis, many potential therapies are now emerging. The requirements for the "perfect therapy" for hepatic fibrosis can be listed: (1) the pharmacologic agent should be active only in the liver; (2) its effect should be specific for collagen (or another critical extracellular ...
D A, Brenner, J M, Alcorn
openaire +2 more sources
Deferiprone and hepatic fibrosis
Blood, 2003We write to request that Wanless and colleagues correct the record on the efficacy and safety of deferiprone for treatment of transfusional iron overload by providing the data on hepatic iron omitted from their publication in Blood.
Gary M, Brittenham +6 more
openaire +2 more sources
Current Gastroenterology Reports, 2018
The purpose of this review is to discuss the current imaging techniques for non-invasive assessment of liver fibrosis (LF).Elastography-based techniques are the most widely used imaging methods for the evaluation of LF. Currently, MR elastography (MRE) is the most accurate non-invasive method for detection and staging of LF.
Rishi Philip, Mathew +1 more
openaire +2 more sources
The purpose of this review is to discuss the current imaging techniques for non-invasive assessment of liver fibrosis (LF).Elastography-based techniques are the most widely used imaging methods for the evaluation of LF. Currently, MR elastography (MRE) is the most accurate non-invasive method for detection and staging of LF.
Rishi Philip, Mathew +1 more
openaire +2 more sources